Friday, March 17, 2017 11:23:39 AM
March 17, 2017 - News Release (Re: Pharmaceutical Agreement):
Understood worldwide for our Diagnostic Kit Development and Manufacturing, including ELISA Kits and HIV p24 Ag, Western Blots, Oxidative Stress Kits, Marketing & Proficiency Panels, Rapid Test Controls, CLIA Validations, QC Controls, numerous Reagents and Biorepository Services, our Team prides themselves on their significant, trusted and daily contributions provided to a global marketplace
ZeptoMetrix operates from three highly efficient, state of the art facilities. Our Corporate Headquarters is situated in Buffalo, New York on the Buffalo-Niagara Medical Campus. Responsible for Research & Development and its new Analytical Testing Services, Buffalo is home to 2 – Bio Safety Level 3 Laboratories and has been granted a Select Agent License. Franklin, Massachusetts is home to our FDA Registered Facility-Molecular Diagnostics Division, Biorepository Services, Manufacturing and Distribution Fulfillment Services
Our ZeptoMetrix Team represents a cross section of the best and brightest in our Industry. From our highly skilled and ground-breaking Scientific Team to the collaborative, detailed and experience of our Manufacturing and Distribution Groups, ZeptoMetrix is focused on delivering unparalleled quality, consistency, innovation and trust in our Company, Products and Services provided to our Global Partners and Industry. Together we look forward toward leading, building and establishing new standards for the Global good.
www.zeptometrix.com/about/
ZeptoMetrix - Known to have one of the world’s largest commercial archives of clinical specimens, ZeptoMetrix possesses a significant scope of stocked, highly characterized Seroconversion Panels from HIV, HBV and HCV infected Individuals.
Question: What is a Seroconversion Panel?
Answser: Its a testing panel designed to test the testing device in question.
So, for example, you and I devise a new HIV testing kit which we think is great.
We can buy commercial testing panels containing HIV antibodies or antigens or both where the effectiveness or accuracy of other HIV tests which we are going to be selling against, is already known. That way we can test our new test against the best available tests already available and see how good ours is in terms of corretly identifying HIV.
ZeptoMetrix Info:
U.S. Representative Chris Collins:
James Hengst, Ph.D., Co-founder and Chief Executive Officer
/////AMG
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM